Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
European Journal of Haematology
|
November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
Francesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.
Haematologica
|
September 21, 2004
The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma
Alessandro Corso, Luciana Barbarano, Patrizia Zappasodi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 7, 2020
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses
Mario Amore, Martino Belvederi Murri, Pietro Calcagno, et al.
The New England Journal of Medicine
|
May 11, 2012
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
Antonio Palumbo, Roman Hajek, Michel Delforge, et al.
Annals of Hematology
|
October 25, 2018
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)
Pellegrino Musto, Vittorio Simeon, Nicola Cascavilla, et al.
European Journal of Haematology
|
September 8, 2021
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
Paul G Richardson, Fredrik Schjesvold, Katja Weisel, et al.
BMC Cancer
|
November 1, 2025
Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework
Mario Boccadoro, Angelo Belotti, Felice Bombaci, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 22, 2018
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
Mohamad Mohty, Evangelos Terpos, Maria-Victoria Mateos, et al.
European Journal of Haematology
|
January 15, 2026
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations
Alessandro Corso, Monia Marchetti, Monica Galli, et al.
Hematological Oncology
|
February 3, 2025
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
European Journal of Haematology
|
November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
Francesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.
Haematologica
|
September 21, 2004
The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma
Alessandro Corso, Luciana Barbarano, Patrizia Zappasodi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 7, 2020
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses
Mario Amore, Martino Belvederi Murri, Pietro Calcagno, et al.
The New England Journal of Medicine
|
May 11, 2012
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
Antonio Palumbo, Roman Hajek, Michel Delforge, et al.
Annals of Hematology
|
October 25, 2018
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)
Pellegrino Musto, Vittorio Simeon, Nicola Cascavilla, et al.
European Journal of Haematology
|
September 8, 2021
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
Paul G Richardson, Fredrik Schjesvold, Katja Weisel, et al.
BMC Cancer
|
November 1, 2025
Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework
Mario Boccadoro, Angelo Belotti, Felice Bombaci, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 22, 2018
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
Mohamad Mohty, Evangelos Terpos, Maria-Victoria Mateos, et al.
European Journal of Haematology
|
January 15, 2026
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations
Alessandro Corso, Monia Marchetti, Monica Galli, et al.
Hematological Oncology
|
February 3, 2025
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, et al.
Page
of 6